Ad
related to: strep pneumoniae optochin resistant treatment options for women- Antimicrobial Activity
A list of susceptible pathogens in
clinical infections and/or in vitro
- CABP Patient Types
See if your patients could be
eligible for this treatment.
- Pharmacy Network Finder
Use the finder to locate
pharmacies that carry our drug
- Prescribing Information
Visit official HCP website and find
full Prescribing Information.
- Antimicrobial Activity
Search results
Results from the WOW.Com Content Network
Optochin (or ethylhydrocupreine hydrochloride) is a derivative of quinine introduced in 1911 by Morgenroth and Levy with the intention to treat pneumococci infection. [1] In very high dilutions, it inhibits the growth of representatives of all four groups of pneumococci in vitro .
Streptococcus pneumoniae can be differentiated from the viridans streptococci, some of which are also alpha-hemolytic, using an optochin test, as S. pneumoniae is optochin-sensitive. S. pneumoniae can also be distinguished based on its sensitivity to lysis by bile, the so-called "bile solubility test".
Pneumococcal infection is an infection caused by the bacterium Streptococcus pneumoniae. [1]S. pneumoniae is a common member of the bacterial flora colonizing the nose and throat of 5–10% of healthy adults and 20–40% of healthy children. [2]
Viridans streptococci can be differentiated from Streptococcus pneumoniae using an optochin test, as viridans streptococci are optochin-resistant; they also lack either the polysaccharide-based capsule typical of S. pneumoniae or the Lancefield antigens of the pyogenic members of the genus. [5]
Carbapenems are less commonly used in the treatment of community-acquired pneumonia, as community-acquired strains of the most common responsible pathogens (Streptococcus pneumoniae, Haemophilus influenazae, atypical bacteria, and Enterobactericeace) are typically susceptible to narrower spectrum and/or orally administered agents such as ...
Linezolid is an antibiotic used for the treatment of infections caused by Gram-positive bacteria that are resistant to other antibiotics. [9] [10] Linezolid is active against most Gram-positive bacteria that cause disease, including streptococci, vancomycin-resistant enterococci (VRE), and methicillin-resistant Staphylococcus aureus (MRSA).
Streptococcus pseudopneumoniae is a gram-positive coccus that may cause pneumonia in humans. [1] [2] It was first described in 2004. [1] The organism is often mistaken for S. pneumoniae [1] and its clinical importance is as yet uncertain. It seems likely that most cases of S. pseudopneumoniae pneumonia are misdiagnosed as S. pneumoniae. [2]
With the increase in drug-resistant Streptococcus pneumoniae, antibiotics such as cefpodoxime may become more popular. [21] Hospitalized children receive intravenous ampicillin, ceftriaxone or cefotaxime, and a recent study found that a three-day course of antibiotics seems sufficient for most mild-to-moderate CAP in children. [22]
Ad
related to: strep pneumoniae optochin resistant treatment options for women